S10A9_HUMAN MRP14 ELISA tesk kit

Price:

1 011.15 €

Known as:: S10A9_HUMAN MRP14 Enzyme-linked immunosorbent assay test tesk reagent
Catalog number:: gen17445
Product Quantity:: 1
Category:: Peptides
Supplier:: Other suppliers
Gene target:: S10A9_HUMAN MRP14 ELISA tesk kit

Related genes to: S10A9_HUMAN MRP14 ELISA tesk kit

Gene:: S100A9 ^{NIH gene}
Name:: S100 calcium binding protein A9
Previous symbol:: CAGB, CFAG
Synonyms:: P14, MIF, NIF, LIAG, MRP14, MAC387, 60B8AG, CGLB
Chromosome:: 1q21.3
Locus Type:: gene with protein product
Date approved:: 1989-05-19
Date modifiied:: 2018-05-02

Related products to: S10A9_HUMAN MRP14 ELISA tesk kit

[Tyr63] PTH (63_84), human Human ELC ELISA KIT 96 TEST OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size OxiSelect Methylglyoxal (MG) Competitive ELISA Kit OxiSelect Methylglyoxal (MG) Competitive ELISA Kit OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size"Recombinant Human Carboxypeptidase E_CPE""Recombinant Human Carboxypeptidase E_CPE""Recombinant Human Carboxypeptidase E_CPE""Recombinant Human Carboxypeptidase E_CPE""Recombinant Human Carboxypeptidase E_CPE""Recombinant Human Carboxypeptidase E_CPE""Recombinant Human Carboxypeptidase E_CPE"

Related articles to: S10A9_HUMAN MRP14 ELISA tesk kit

Characterization of the stages of chronic liver disease based on plasma proteins involved in systemic inflammation.
Cirrhosis is characterized by progressive fibrosis, portal hypertension, and cirrhosis-associated immune dysfunction, combining systemic inflammation and immunodeficiency. Although systemic inflammation plays a central role in disease progression and complications, current prognostic scores do not incorporate inflammatory biomarkers. This study aimed to characterize stages of chronic liver disease (CLD) according to a panel of plasma proteins involved in systemic inflammation in patients with and without bacterial infection. - Source: PubMed
Publication date: 2026/07/13
Fortuny MartaTorner MariaBermúdez-Ramos MaríaArdèvol AlbaMorales CristianBartolí RamónMorillas Rosa MDomènech EugeniSarrias Maria RosaMasnou Helena
S100A8/S100A9 Links Diabetic Stress to Cardiac Progenitor Cell Dysfunction and Fibrotic Heart Failure: An Integrated Transcriptomic, Single-Cell, and Functional Study.
Diabetes markedly increases the risk of heart failure, yet the molecular signals connecting metabolic stress, myocardial fibrosis, and impaired cardiac repair remain incompletely understood. - Source: PubMed
Publication date: 2026/07/11
Yang YangCao Ge
Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer.
To explore mesenchymal stem cell (MSC)-driven metabolic reprogramming of EGFR-wild-type (EGFR-wt) tumor cells contributing to tyrosine kinase inhibitor (TKI) resistance in EGFR-mutant (EGFR-mt) non-small cell lung cancer. - Source: PubMed
Publication date: 2026/07/11
Bie HongyuLi JiaruiLiu JialinZhou JianWang TierunGuo XuLiu JiaweiYou YiHuang HuiLi ShijiaLi WanqiaoRen XiubaoWang MengZhang WenchengYan Cihui
Single-cell RNA sequencing and cross-species analysis revealed the role of T cell-driven inflammatory responses in the pathogenesis of aortic dissection.
Aortic dissection (AD) is a life-threatening vascular condition characterized by acute inflammation and structural deterioration of the aortic wall. This study aimed to delineate the immune landscape, particularly T cell-mediated responses, and identify conserved inflammatory mechanisms driving AD pathogenesis across human and murine models. - Source: PubMed
Publication date: 2026/07/11
Zhang ShenZhang YongguiSun YaodongZhu MinfangWu Naishi
Erdosteine Provides Effective Analgesia in Inflammatory Pain Without Impairing Pain Resolution: A Preclinical Comparison With Non-Steroidal Anti-Inflammatory Drugs.
Nonsteroidal anti-inflammatory drugs (NSAIDs) provide effective analgesia but may paradoxically delay tissue recovery, pain resolution and contribute to chronic pain. Erdosteine, a thiol-based prodrug with antioxidant and anti-inflammatory properties, is a mucolytic used for treatment of respiratory diseases but has recently been suggested to possess analgesic potential. - Source: PubMed
Vasconcelos Lima LucasKaraky MohamadYu GraceAllegri MassimoMarchesi NicolettaGovoni StefanoPage CliveDiatchenko Luda

S10A9_HUMAN MRP14 ELISA tesk kit

Related genes to: S10A9_HUMAN MRP14 ELISA tesk kit

Related products to: S10A9_HUMAN MRP14 ELISA tesk kit

Related articles to: S10A9_HUMAN MRP14 ELISA tesk kit

Characterization of the stages of chronic liver disease based on plasma proteins involved in systemic inflammation.

S100A8/S100A9 Links Diabetic Stress to Cardiac Progenitor Cell Dysfunction and Fibrotic Heart Failure: An Integrated Transcriptomic, Single-Cell, and Functional Study.

Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer.

Single-cell RNA sequencing and cross-species analysis revealed the role of T cell-driven inflammatory responses in the pathogenesis of aortic dissection.

Erdosteine Provides Effective Analgesia in Inflammatory Pain Without Impairing Pain Resolution: A Preclinical Comparison With Non-Steroidal Anti-Inflammatory Drugs.